Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...
Lupin gained 3.66% to Rs 2,188 after the company announced that it has received a tentative approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Darunavir, Cobicistat, ...
You know you've said it. We all have. ''Mmm, that looks so delicious — I want to try some!'' That's because when it comes to what we eat, it's not just a matter of taste.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results